ArticleFrontiers in neuroscience2016

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy.

José Marco-Contelles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.